KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Income towards Parent Company (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Income towards Parent Company for 16 consecutive years, with $1.8 billion as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Income towards Parent Company rose 10.69% year-over-year to $1.8 billion, compared with a TTM value of $7.9 billion through Dec 2024, up 385.78%, and an annual FY2025 reading of $6.8 billion, up 5.97% over the prior year.
  • Income towards Parent Company was $1.8 billion for Q4 2024 at Thermo Fisher Scientific, up from $1.7 billion in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $2.5 billion in Q4 2020 and bottomed at $788.0 million in Q1 2020.
  • Average Income towards Parent Company over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2022.
  • The sharpest move saw Income towards Parent Company skyrocketed 196.57% in 2021, then plummeted 41.94% in 2023.
  • Year by year, Income towards Parent Company stood at $2.5 billion in 2020, then tumbled by 35.94% to $1.6 billion in 2021, then dropped by 2.94% to $1.6 billion in 2022, then rose by 4.39% to $1.6 billion in 2023, then increased by 10.69% to $1.8 billion in 2024.
  • Business Quant data shows Income towards Parent Company for TMO at $1.8 billion in Q4 2024, $1.7 billion in Q3 2024, and $1.6 billion in Q2 2024.